WNT5A and Insulin resistance: The connection between WNT5A expression in VAT and IL-6/CRP levels is of particular relevance, given the large body of clinical evidence that links increased IL-6 signaling and/or increased circulating CRP levels to insulin resistance, diabetes and atherosclerotic CVD4,40–43.